newsfilter
← Latest News
GlobeNewswire·

Oncotelic Announces Peer-Reviewed Publication Validating Deciparticle™ Technology Supporting the Ongoing Clinical Development of Sapu003 (IV everolimus)

AGOURA HILLS, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) and Sapu Nano today announced the publication of a comprehensive peer-reviewed study in Biomedicines describing the